GudvyoShadi Vati and Shatpushpa Siddha Taila Nasya in the Management of Artavkshaya

Phase 2/3

Not yet recruiting

• Conditions: Oligomenorrhea, unspecified. Ayurveda Condition: ARTAVAKSHAYAH,

• Registration Number: CTRI/2025/03/083115
• Lead Sponsor: PGIA,JODHPUR,RAJASTHAN,INDIA

Brief Summary

Primary Objective  To evaluate the effect of Gudvyoshadi Vati and Shatpushpa Siddha Taila Nasya on Artavkshaya. This is a single group experimental interventional study. A group of Diagnosed 30 patients between After 3 years of menarche to 40 yrs of Age and having Hypomenorrhoea ( scanty menses )- Score less than 10 on PBLAC and  Oligomenorrhea ( delayed menses -Interval of more than 35 days) will be registered .  Treatment will be given GudvyoShadi vati 1gm BD Starting 7 days before expected date of menstrual cycle for 7 days and Shatpushpa Siddha taila pratimarsh nasya 2 drops in each nostril OD starting After cessation of menses to 14th day of menstrual cycle by nasal route for 2 consecutive  menstrual cycles.

The clinical assessment criteria will be based on grading and scoring system of Duration of menstrual bleeding, Interval between two cycles ,Amount of menstrual flow, Pain during menstruation.

Detailed Description

Not available

Study Timeline

• Study Start: 2025-01-05
• Last Update Posted: 2025-08-03

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

• Patients willing for the trial Patient between the age After 3 years of menarche to 40 years of age.
• Oligomenorrhea (delayed menses -Interval of more than 35 days) Hypomenorrhea (scanty menses)- Score less than 10 on PBLAC.

Exclusion Criteria

• Patient less than 3 years of menarche and more than 40 years of age.
• Lactating women.
• Patients with any reproductive system abnormalities like hydrosalpinx, fibroid uterus, carcinoma of reproductive organ and sexually transmitted disease (STDs), Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antigen (HBsAg).
• Systemic disorders like-uncontrolled diabetes mellitus, chronic liver disease, renal disorder, Uncontrolled hypertension, Diagnosed case of any type of malignancy.
• Patients who are contraindicated for Nasya like, Nasal polyp etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessment of	28 Days | (2 consecutive menstrual cycles)
Interval between two cycles	28 Days | (2 consecutive menstrual cycles)
Amount of menstrual flow.	28 Days | (2 consecutive menstrual cycles)
SUBJECTIVE PARAMETERS	28 Days | (2 consecutive menstrual cycles)
Pain during menstruation.	28 Days | (2 consecutive menstrual cycles)
OBJECTIVE PARAMETERS	28 Days | (2 consecutive menstrual cycles)
Duration of menstrual bleeding	28 Days | (2 consecutive menstrual cycles)
Serum LH and serum FSH level test	28 Days | (2 consecutive menstrual cycles)
Thyroid stimulating hormone test (TSH)	28 Days | (2 consecutive menstrual cycles)
Ultrasonography (Pelvis)	28 Days | (2 consecutive menstrual cycles)

Secondary Outcome Measures

Name	Time	Method
To Assess improvement in	SUBJECTIVE PARAMETERS

Trial Locations

Locations (1)

Post Graduate Institute of Ayurved, Jodhpur, Rajasthan; 🇮🇳 Jodhpur, RAJASTHAN, India

Post Graduate Institute of Ayurved, Jodhpur, Rajasthan

🇮🇳Jodhpur, RAJASTHAN, India

Dr Bhumika Sharma

Principal investigator

9460681599

sharmabhumika52@gmail.com